Feasibility of breast conserving surgery alone in HER2-positive exceptional responders to neoadjuvant systemic therapy
Year: 2024
Type: article
Study design: Clinical Trial
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4401736261
